Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 survey

BACKGROUND: Many patients with coronary artery disease (CAD) have overlapping gastroenterological causes of recurrent chest pain, mainly due to gastroesophageal reflux (GER) and aspirin-induced gastrointestinal tract damage. These symptoms can be alleviated by proton pump inhibitors (PPIs). The stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Budzyński, Jacek, Pulkowski, Grzegorz, Suppan, Karol, Fabisiak, Jacek, Majer, Marcin, Kłopocka, Maria, Galus-Pulkowska, Beata, Wasielewski, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186737/
https://www.ncbi.nlm.nih.gov/pubmed/21939510
http://dx.doi.org/10.1186/1477-7525-9-77

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186737/
https://www.ncbi.nlm.nih.gov/pubmed/21939510
http://dx.doi.org/10.1186/1477-7525-9-77

Ejemplares similares